Latest Europe News

Gentrack Group Limited reported a solid 9.8% revenue increase to NZ$112 million in the first half of FY25, powered by strong recurring revenue growth in utilities and a surge in its airports division, Veovo. Net profit after tax jumped 34.7%, supported by currency gains and a lower tax rate.

Gentrack Group Ltd reported a robust 9.8% revenue increase and a 34.7% jump in net profit for the first half of FY25, driven by strong recurring revenues and strategic global expansion.

Medallion Metals has raised $27.5 million through a well-supported institutional placement to accelerate its gold and copper production strategy by acquiring Forrestania’s processing infrastructure. This funding positions the company to advance drilling, feasibility studies, and a final investment decision by late 2025.

Mesoblast has been granted a seven-year orphan-drug exclusivity by the FDA for its cell therapy Ryoncil, reinforcing its market position in treating steroid-refractory acute graft versus host disease in children.

Proteomics International Laboratories has secured a key Chinese patent for its OxiDx oxidative stress test, broadening its intellectual property coverage across major global markets until 2039. This milestone reinforces the company’s position in precision diagnostics for sports and veterinary health.

EQ Resources has secured an extension of credit facilities from its major shareholder Oaktree, ensuring continued operations at its flagship Barruecopardo tungsten mine in Spain through 2025. The company is also actively restructuring its debt to strengthen its financial position amid improving production and market conditions.

Unibail-Rodamco-Westfield unveils a confident 2025-28 strategy targeting robust EBITDA growth, expanding retail media, and increased shareholder returns. The plan balances disciplined capital allocation with ambitious development and licensing initiatives.

Alliance Aviation Services has updated its FY25 financial guidance, aiming for EBITDA between $205-210 million while navigating operational disruptions and planning significant debt reduction by 2026.

Talga Group has locked in a binding multi-year offtake agreement with Nyobolt for its Talnode-C graphite anode, marking a key commercial milestone for its Vittangi Anode Project in Sweden.

Aristocrat Leisure Limited reported a robust HY25 with revenue rising 9% to AUD 3 billion and a 6% increase in NPATA, underpinned by strategic acquisitions and operational resilience. The company signals confidence in sustained growth through innovation and market expansion.

Anteris Technologies has submitted its FDA Investigational Device Exemption for the pivotal PARADIGM Trial of its DurAVR heart valve and marked a milestone of 100 patients treated, while expanding manufacturing capacity amid rising R&D costs.

Aristocrat Leisure reported a robust first half FY2025 with 9% revenue growth and a 6% rise in normalised NPATA, driven by strategic acquisitions and market share gains. The company returned $533 million to shareholders while positioning for sustained growth across its gaming portfolio.